from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3868/eccA1

LFCtreatmentdescriptionclass of inhibitor

-2.493

Amikacinug/mL Amikacintranslation

-2.493

Cap5-10ug/mL Capreomycintranslation

-1.923

Rox10-50 ug/mL Roxithromycintranslation

-0.392

SM2-5 ug/mL Streptomycintranslation

-1.457

Tet5-10 ug/mL Tetracyclinetranslation

-0.595

Rif0.2-5ug/mL Rifampicintranscription

-0.417

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.492

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.029

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.381

CPZ10-50 ug/mL Chlorpromazinerespiration

1.496

Clofazimine10-13 ug/mL Clofaziminerespiration

0.367

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.461

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.365

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.563

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.402

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.385

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.995

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.013

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.058

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.282

KCN5-20 ug/mL Potassium cyaniderespiration

0.286

NaN30.2-2 mM Sodium aziderespiration

0.387

Nigericin50 uM Nigericinrespiration

0.609

TRC10-150 ug/mL Triclosanrespiration

0.566

TRZ10-25 ug/mL Thioridazinerespiration

0.391

Valinomycin0.5-10 uM Valinomycinrespiration

0.551

ZnSO42 mM ZnSO4respiration

-0.038

menadione6-10 ug/mL Menadionerespiration

0.395

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.131

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.435

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.019

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.639

NRP_1Non-replicating persistence stage 1dosRassociated

0.690

Amp0.2mg/mL AmpicillincellWall

-0.062

Cephalexin20-100 ug/mL CephalexincellWall

-0.387

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.367

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.095

EMB10-20 ug/mL EthambutolcellWall

-0.342

Eta12-40 ug/mL EthionamidecellWall

-0.731

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.164

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.123

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.305

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.387

BZA0.12 mg/mL BenzamidearomaticAmides

-0.928

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.865

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.533

H2O24 mM hydrogen peroxideDNAdamaging

-0.285

Levo10 ug/mL LevofloxacinDNAdamaging

0.137

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.991

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.077

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.007

UVUV-irradiationDNAdamaging

-0.648

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.347

Antimycin12.5-50 ug/mL Antimycin A?

-0.052

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.926

PA8240.2-2 ug/mL PA-824?

-0.315

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.266

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.489

Verapamil50 uM Verapamil?

-0.217

mercaptoethanol2 mM 2-Mercaptoethanol?

0.185

methoxatin10-20 ug/mL Methoxatin?